semaglutide cardiac protection GLP-1 Agonists in Cardiovascular Diseases: Mechanisms, Clinical Evidence, and Emerging Therapies Proposed direct mechanisms of cardiovascular – Stopping GLP-1 drugs can quickly

Another 6 genes work in APX-GSH cycle, which determines the antioxidant activity of glutathione signaling pathway, are differentially expressed at transcription level

They showed a higher myocardial capillary density and cardiac performance in comparison to other groups

Major clinical trials demonstrate that these drugs lower major adverse cardiovascular events like myocardial infarction and stroke [8]

Directions and Dosages: Take 1-2 capsules 1 to 2 times daily between meals

SK: Funding acquisition, Project administration, Writing review & editing, Conceptualization

timing depends on individual factors including gastrointestinal tolerance, circadian metabolism, and lifestyle